Founder, President & CEO

How to navigate the whisky cask boom

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

Braeburn gets FDA approval for opioid use disorder drug after more than 4-year battle

FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder

Medical Science Liaison

Braeburn is dedicated to delivering solutions for people living with opioid use disorder. The Medical Science Liaison (MSL) serves as a scientific resource, building relationships with Key Opinion Leaders and providing medical information and education to ensure safe and effective product utilization.

Sign up with Google

Sign in with Google